B Cell - you were expecting a deal when they haven't even started Ph1 clinical trial lol.
HER-Vaxx - this has completed Ph2 clinical trial so I'm not sure what you are talking about again lol.
PD1-Vaxx - starting Ph2 clinical trial this year so I'm not sure what you are talking about again lol.
CHECVacc - TNBC is already covered in the VAXINIA clinical trial so why would they continue with this clinical trial and waste money???? I suspect it will work better combined with CD19 anyway as these tumour express T Cell.
CF33/OnCARlytic - Yes, still waiting for over 18 months.......
IMU Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)